Filter by:
This briefing paper describes the regulatory models that have been implemented since 2014 in the American states that have legalised cannabis, highlighting their differences and similarities. It also discusses the reform processes and common features of states that have legalised cannabis for medical and recreational use.
In 2018, two major international surveys Health Behaviour in School-aged Children (HBSC) and European School Project on Alcohol and other Drugs (ESPAD) were carried out simultaneously for the first time in France, using a unified scientific framework.
Since 1999, the OFDT has been quantifying the opinions and perceptions of the French population on drugs and related public policies through the EROPP survey (Survey on representations, opinions and perceptions regarding psychoactive drugs).
This summary covers the main contributions from a collective OFDT publication entitled "Drogues et addictions, données essentielles" issued in April 2019.
As a minority in specialised care services, French women presenting with addictions represent 23% and 18% of the public seen in specialised drug treatment centres (CSAPA) and harm reduction facilities (CAARUD) respectively.
In the wake of the 2017 findings, the year 2018 was marked by a sharp decline in cigarette and of roll-your-own tobacco sales in France's tobacconist network. However, a slight increase in other types of tobacco, less heavily taxed, can be seen, together with a likely increase in cross-border purchases.
This eight-page document provides the most relevant figures for measuring and providing a quick overview of drug-related phenomena.
Since 1999, the Emerging Trends and New Drugs (TREND) scheme of the French Monitoring Centre for Drugs and Drug Addiction (OFDT) has been monitoring emerging trends and phenomena in the field of drugs in order to limit the time between their occurrence and their consideration by the public authorities.
Based on the findings of the 2017 Health Barometer Survey of Santé publique France (data processed by OFDT) which interviewed over 20 000 people aged 18 to 64 years, this issue of Tendances describes the changes in illicit drug use and offers an overview of cannabis supply modes.
Following Uruguay in 2013, Canada is the second country in the world - the first in G7 - that has officially legalised the production, distribution and possession of cannabis for recreational use.
Ten years after the emergence of new psychoactive substances (NPS), the available data reveal lower detection rates for new substances, and their use is still somewhat limited in France.
The objective of this issue is to offer a glimpse into tobacco use in Western countries, using prevalence surveys, annual data on tobacco sales and average tobacco prices.
The objective of this issue of Drugs, international challenges is to take stock of the relations sustained by drug control and development policies, initially returning to the concept of "alternative development" so as to clarify its intricacies and limitations.
The downward trend in official tobacco sales observed in 2016 has been confirmed in 2017 (characterised by a very powerful symbolic measure, plain packaging) with the marked decline in roll-your-own tobacco owing to its lower price.
For the ninth time since the implementation of the ESCAPAD survey, the French Monitoring Centre for Drugs and Drug Addiction (OFDT) and the Youth and National Service Directorate of the Ministry of the Armed Forces interviewed a sample of young people aged 17 years, taking part in the National Defence and Citizenship Day (JDC).
The ARAMIS study (Attitudes, perceptions, aspirations and motives surrounding the introduction to psychoactive substances) aims to explore the perceptions and motives for drug use among minors, and their trajectories for alcohol, tobacco, cannabis and/or other illicit drug use.
Since 1999, the OFDT TREND scheme (Emerging Trends and New Drugs) has been monitoring current trends and those concerning emerging phenomena in the field of drugs.
Support centres for the reduction of drug-related harms (CAARUDs) are designed to carry out harm reduction measures aimed at psychoactive substance users. Tendances No 120 presents the 2015 results of a national survey of users attending these centres, named "ENa-CAARUD".
Captagon, in the overwhelming majority of cases, aside from the classic "fakes", is now simply another "street name" for amphetamine or speed.
Since 2007, OFDT has been publishing Drugs, Key Data, an overall perspective digest with the most recent and detailed facts and figures.
